1 terminated, 1 unknown, 1 withdrawn. 1 Early Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow CREST Syndrome: new trials by email Literature Review of CREST Syndrome trials Research Report on CREST Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease hyaluronidase injected intradermally - Microstomia, Scleroderma | Early Phase 1 | Withdrawn | Brigham and Women's Hospital | 2020-01-01 | 2021-01-14 | |
| Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon INOMAX - CREST Syndrome, Calcinosis Cutis | Unknown | RoseLab Skin Optics Laboratory | 5 | 2019-06-20 | 2019-06-03 | |
| Exparel as a Nerve Block for Severe Hand Pain liposomal bupivacaine - CREST Syndrome, Peripheral Vascular Disease | Phase 2 / Phase 3 | Terminated | Jose Soberon, MD | 13 | 2014-11-01 | 2024-05-21 |
Raynaud Disease (2) · Scleroderma, Diffuse (2) · Calcinosis Cutis (1) · Microstomia (1) · Peripheral Vascular Diseases (1) · Scleroderma, Localized (1) · Scleromyxedema (1)
Calcinosis (3) · Calcium Metabolism Disorders (3) · Cardiovascular Diseases (3) · Connective Tissue Diseases (3) · Deglutition Disorders (3) · Digestive System Diseases (3) · Embolism and Thrombosis (3) · Esophageal Diseases (3) · Esophageal Motility Disorders (3) · Gastrointestinal Diseases (3) · Livedoid Vasculopathy (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Scleroderma, Limited (3) · Scleroderma, Systemic (3)
Endothelium-Dependent Relaxing Factors (1)
Brigham and Women's Hospital (1) · Jose Soberon, MD (1) · RoseLab Skin Optics Laboratory (1)
Canada (1) · United States (1)
Jose Soberon, MD (1)